ArticlePloS one2025
A novel and robust feature selection method with FDR control for omics-wide association analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Omics-wide association analysis is a very important tool for medicine and human health study. However, the modern omics data sets collected often exhibit the high-dimensionality, unknown distribution response, unknown distribution features and unknown complex association relationships between the response and its explanatory features. Reliable association analysis results depend on an accurate modeling for such data sets. Most of the existing association analysis methods rely on the specific model assumptions and lack effective false discovery rate (FDR) control. To address these limitations, the paper firstly applies a single index model for omics data. The model shows robust performance in allowing the relationships between the response variable and linear combination of covariates to be connected by any unknown monotonic link function, and both the random error and the covariates can follow any unknown distribution. Then based on this model, the paper combines rank-based approach and symmetrized data aggregation approach to develop a novel and robust feature selection method for achieving fine-mapping of risk features while controlling the false positive rate of selection. The theoretical results support the proposed method and the analysis results of simulated data show the new method possesses effective and robust performance for all the scenarios. The new method is also used to analyze the two real datasets and identifies some risk features unreported by the existing finds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.